PFIZER INC Public Float
PFIZER INC (PFE) had Public Float of $138.00 billion as of 2025-06-29, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-29: Entity Public Float $138.00B.
- 2024-06-30: Entity Public Float $158.00B.
- 2023-07-02: Entity Public Float $207.00B.
- 2022-07-03: Entity Public Float $294.00B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-29 | $138.00B 10-K · filed 2026-02-26 |
| 2024-06-30 | $158.00B 10-K · filed 2025-02-27 |
| 2023-07-02 | $207.00B 10-K · filed 2024-02-22 |
| 2022-07-03 | $294.00B 10-K · filed 2023-02-23 |
| 2021-07-04 | $223.00B 10-K · filed 2022-02-24 |
| 2020-06-28 | $169.00B 10-K · filed 2021-02-25 |
| 2019-06-30 | $241.00B 10-K · filed 2020-02-27 |
| 2018-07-01 | $212.00B 10-K · filed 2019-02-28 |
| 2017-07-02 | $200.00B 10-K · filed 2018-02-22 |
| 2016-07-03 | $216.00B 10-K · filed 2017-02-23 |
| 2015-06-28 | $209.00B 10-K · filed 2016-02-29 |
| 2014-06-27 | $188.00B 10-K · filed 2015-02-27 |
| 2013-06-28 | $186.00B 10-K · filed 2014-02-28 |
| 2012-06-29 | $172.00B 10-K · filed 2013-02-28 |
| 2011-07-01 | $163.00B 10-K · filed 2012-02-28 |
| 2010-07-04 | $114.00B 10-Q · filed 2011-05-12 |
| 2009-06-26 | $102.00B 10-Q · filed 2010-11-12 |
| 2008-06-29 | $116.00B 10-Q · filed 2009-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |